Gene therapy for disc degeneration (Q36717342)

15 August 2017

1 reference

title

Gene therapy for disc degeneration (English)

1 reference

15 August 2017

0 references

Gianluca Vadalà

1

1 reference

15 August 2017

Gwendolyn A Sowa

series ordinal

2

1 reference

15 August 2017

James D Kang

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Expert Opinion on Biological Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

185-196

1 reference

Estimates and patterns of direct health care expenditures among individuals with back pain in the United States

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Lumbar disc degeneration: epidemiology and genetic influences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

An allele of COL9A2 associated with intervertebral disc disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Identification of a novel common genetic risk factor for lumbar disk disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Degeneration and the chemical composition of the human lumbar intervertebral disc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Nutrition of the intervertebral disc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Growth factors and treatment of intervertebral disc degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Safety assessment of intradiscal gene transfer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Delayed expression of adeno-associated virus vector DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Adenovirus and adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Transduced bovine articular chondrocytes affect the metabolism of cocultured nucleus pulposus cells in vitro: implications for chondrocyte transplantation into the intervertebral disc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Gene Transfer of the Catabolic Inhibitor TIMP-1 Increases Measured Proteoglycans in Cells from Degenerated Human Intervertebral Discs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Gene therapy death prompts review of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Management of spinal brucellosis and outcome of rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Ecdysone-controlled expression of transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Electrochemical measurement of transport into scoliotic intervertebral discs in vivo using nitrous oxide as a tracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

Gene therapy. Safer and virus-free?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.2.185

21 January 2018

Identifiers

DOI

10.1517/14712598.7.2.185

1 reference

15 August 2017

1 reference